Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?

SIMPLE SUMMARY: Breast cancer is the most frequently diagnosed cancer in women, causing over 500,000 deaths worldwide. Human epidermal growth factor receptor 2 is overexpressed in roughly 15–20% of the breast cancer cases diagnosed nowadays, denoting poor prognoses. However, the presence of this rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gherghe, Mirela, Lazar, Alexandra Maria, Mutuleanu, Mario-Demian, Bordea, Cristian Ioan, Ionescu, Sinziana, Mihaila, Raluca Ioana, Petroiu, Cristina, Stanciu, Adina Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818586/
https://www.ncbi.nlm.nih.gov/pubmed/36612202
http://dx.doi.org/10.3390/cancers15010207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818586/
https://www.ncbi.nlm.nih.gov/pubmed/36612202
http://dx.doi.org/10.3390/cancers15010207

Ejemplares similares